Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

The oral administration of dapsone (DAP) for the treatment of cutaneous leishmaniasis (CL) is effective, although serious hematological side effects limit its use. In this study, we evaluated this drug for the topical treatment of CL. As efficacy depends on potency and skin penetration, we first det...

Full description

Bibliographic Details
Main Authors: Espuelas, S. (Socorro), Irache, J.M. (Juan Manuel), Sanmartin-Grijalba, C. (Carmen), Gonzalez-Peñas, E. (Elena), Navarro-Blasco, I. (Iñigo), Schwartz, J. (Juana), Calvo-Bacaicoa, A. (Alba), Moreno-Amatria, E. (Esther)
Format: info:eu-repo/semantics/article
Language:English
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/10171/58480
_version_ 1793400393974153216
author Espuelas, S. (Socorro)
Irache, J.M. (Juan Manuel)
Sanmartin-Grijalba, C. (Carmen)
Gonzalez-Peñas, E. (Elena)
Navarro-Blasco, I. (Iñigo)
Schwartz, J. (Juana)
Calvo-Bacaicoa, A. (Alba)
Moreno-Amatria, E. (Esther)
author_facet Espuelas, S. (Socorro)
Irache, J.M. (Juan Manuel)
Sanmartin-Grijalba, C. (Carmen)
Gonzalez-Peñas, E. (Elena)
Navarro-Blasco, I. (Iñigo)
Schwartz, J. (Juana)
Calvo-Bacaicoa, A. (Alba)
Moreno-Amatria, E. (Esther)
author_sort Espuelas, S. (Socorro)
collection DSpace
description The oral administration of dapsone (DAP) for the treatment of cutaneous leishmaniasis (CL) is effective, although serious hematological side effects limit its use. In this study, we evaluated this drug for the topical treatment of CL. As efficacy depends on potency and skin penetration, we first determined its antileishmanial activity (IC50 = 100 ¿M) and selectivity index in vitro against Leishmania major-infected macrophages. In order to evaluate the skin penetration ex vivo, we compared an O/W cream containing DAP that had been micronized with a pluronic lecithin emulgel, in which the drug was solubilized with diethylene glycol monoethyl ether. For both formulations we obtained similar low flux values that increased when the stratum corneum and the epidermis were removed. In vivo efficacy studies performed on L. major-infected BALB/c mice revealed that treatment not only failed to cure the lesions but made their evolution and appearance worse. High plasma drug levels were detected and were concomitant with anemia and iron accumulation in the spleen. This side effect was correlated with a reduction of parasite burden in this organ. Our results evidenced that DAP in these formulations does not have an adequate safety index for use in the topical therapy of CL.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-58480
institution Universidad de Navarra
language English
publishDate 2019
record_format dspace
spelling oai:dadun.unav.edu:10171-584802020-03-04T03:56:10Z Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions Espuelas, S. (Socorro) Irache, J.M. (Juan Manuel) Sanmartin-Grijalba, C. (Carmen) Gonzalez-Peñas, E. (Elena) Navarro-Blasco, I. (Iñigo) Schwartz, J. (Juana) Calvo-Bacaicoa, A. (Alba) Moreno-Amatria, E. (Esther) Dapsone Topical treatment Cutaneous leishmaniasis Pluronic lecithin emulgel Iron The oral administration of dapsone (DAP) for the treatment of cutaneous leishmaniasis (CL) is effective, although serious hematological side effects limit its use. In this study, we evaluated this drug for the topical treatment of CL. As efficacy depends on potency and skin penetration, we first determined its antileishmanial activity (IC50 = 100 ¿M) and selectivity index in vitro against Leishmania major-infected macrophages. In order to evaluate the skin penetration ex vivo, we compared an O/W cream containing DAP that had been micronized with a pluronic lecithin emulgel, in which the drug was solubilized with diethylene glycol monoethyl ether. For both formulations we obtained similar low flux values that increased when the stratum corneum and the epidermis were removed. In vivo efficacy studies performed on L. major-infected BALB/c mice revealed that treatment not only failed to cure the lesions but made their evolution and appearance worse. High plasma drug levels were detected and were concomitant with anemia and iron accumulation in the spleen. This side effect was correlated with a reduction of parasite burden in this organ. Our results evidenced that DAP in these formulations does not have an adequate safety index for use in the topical therapy of CL. 2019-11-20T12:41:55Z 2019-11-20T12:41:55Z 2019 info:eu-repo/semantics/article https://hdl.handle.net/10171/58480 en info:eu-repo/semantics/openAccess application/pdf
spellingShingle Dapsone
Topical treatment
Cutaneous leishmaniasis
Pluronic lecithin emulgel
Iron
Espuelas, S. (Socorro)
Irache, J.M. (Juan Manuel)
Sanmartin-Grijalba, C. (Carmen)
Gonzalez-Peñas, E. (Elena)
Navarro-Blasco, I. (Iñigo)
Schwartz, J. (Juana)
Calvo-Bacaicoa, A. (Alba)
Moreno-Amatria, E. (Esther)
Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title_full Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title_fullStr Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title_full_unstemmed Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title_short Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
title_sort evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
topic Dapsone
Topical treatment
Cutaneous leishmaniasis
Pluronic lecithin emulgel
Iron
url https://hdl.handle.net/10171/58480
work_keys_str_mv AT espuelasssocorro evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT irachejmjuanmanuel evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT sanmartingrijalbaccarmen evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT gonzalezpenaseelena evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT navarroblascoiinigo evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT schwartzjjuana evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT calvobacaicoaaalba evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions
AT morenoamatriaeesther evaluationofskinpermeationandretentionoftopicaldapsoneinmurinecutaneousleishmaniasislesions